NVO 240726 127.00P (NVO240726P127000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NVO240726P127000

Watchlist

0.59
+0.36+156.52%

15min DelayTrading Jul 25 15:36 ET

1.62High0.28Low

Intraday

5D
Daily

News

UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
BenzingaJul 24 14:58 ET
Viking Therapeutics Stock Surges 31% As Company Advances Weight Loss Drug To Late-Stage Trial
Benzinga13:48 ET
Novo Nordisk's Wegovy Gets EU Regulator Endorsement to Reduce Heart Risks -- Update
WSJ13:04 ET
Novo Nordisk Wins EU Backing for Wegovy Label Update
Seeking AlphaJul 25 11:48 ET
European Equities Traded in the US as American Depositary Receipts Trend Slightly in Thursday Trading
MT NewswiresJul 25 11:13 ET
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill -- Barrons.com
Barron'sJul 25 11:03 ET

Comments

约翰の理财库

5 hours ago

3 stock entering BigSalesDiscount Zone for Sell Put?

$Domino's Pizza(DPZ.US)$ $Amazon(AMZN.US)$ $Novo-Nordisk A/S(NVO.US)$
Say No More #CashIsKing

BullnBearTrading

Jul 22 22:11

"Trump Trades" Cool Off, Electric Vehicles and Solar Stocks Surge, Oil Stocks Decline

Following President Biden's announcement of withdrawal from the presidential race, stocks expected to benefit from a "Democratic victory," such as renewable energy, solar companies, electric vehicle manufacturers, and cannabis stocks, began to rise. Meanwhile, "Trump trades" like oil and gas, financials, and healthcare stocks began to cool. Analysts suggest that if Harris becomes president, she may adopt more ag...

Biden drops out of presidential race: How will markets react?

103911561

Jul 22 09:42

come back🥳🥳 $Taiwan Semiconductor(TSM.US)$ $Vistra Energy(VST.US)$ $NVIDIA(NVDA.US)$ $Novo-Nordisk A/S(NVO.US)$

Share Your Profit/Loss

Venture Eagle

Jul 18 09:55

Doggy rubbish share

$Novo-Nordisk A/S(NVO.US)$

Meltyy

Jul 17 22:40

Smid-cap obesity stocks hit by $RHHBY positive Ph1 data for oral GLP-1 obesity drug ⚠️

$ROCHE HOLDING AG(RHHBY.US)$
📣 Roche News Snippet:
» CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%)
» data supports once-daily oral dosing regimen
» Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Did you see today's sell-off? 🔴
$Eli Lilly and Co(LLY.US)$ $Novo-Nordisk A/S(NVO.US)$ $Structure Therapeutics(GPCR.US)$ $Viking Therapeutics(VKTX.US)$ $Lipocine(LPCN.US)$